D. E. Shaw & Co., Inc. Inogen Inc Transaction History
D. E. Shaw & Co., Inc.
- $122 Billion
- Q4 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Inogen Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 73,282 shares of INGN stock, worth $568,668. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,282
Previous 150,771
51.4%
Holding current value
$568,668
Previous $1.46 Million
54.1%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding INGN
# of Institutions
146Shares Held
20.9MCall Options Held
88.5KPut Options Held
116K-
Camber Capital Management LP Boston, MA2MShares$15.5 Million0.42% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$12.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.46MShares$11.3 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.36MShares$10.5 Million0.3% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN849KShares$6.59 Million0.0% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $177M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...